Skip to content
Search

Latest Stories

Submit Guest Post

2,286 COVID-19 cases in Pakistan; 32 dead

THE number of COVID-19 cases in Pakistan has jumped to 2,286 on Thursday (2), and the death toll stands at 32.

Punjab province has the highest number of cases at 845, followed by Sindh (743) and KP (276).


The country said that 107 patients have recovered from the disease so far.

Punjab's higher number of positive cases can be attributed to the fact that they have conducted nearly 15,000 Covid-19 tests while Sindh, even with the second-highest number of cases, has conducted nearly 7,000 tests.

Khyber Pakhtunkhwa and Balochistan's testing figures are lower than both Sindh and Punjab.

The country faces lack of testing kits and labs, federal Planning Minister Asad Umar said. He added that the current testing capacity was 280,000 which was expected to increase to 900,000 by April 15.

Meanwhile, Special Assistant to the prime minister on health Dr Zafar Mirza had announced that the government would acquire a synthesiser in a few weeks which would enable the country to start producing testing kits on its own.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weight loss pill

Foundayo is the latest GLP-1 treatment to receive UK approval in tablet form

Representational image: iStock

UK becomes first European nation to approve new weight-loss pill, but NHS access is still pending

  • The UK is the first European country to approve Eli Lilly’s Foundayo pill.
  • The tablet is taken once a day without food or water restrictions.
  • NHS availability will depend on a separate NICE assessment.

The UK has become the first European nation to approve a new daily weight-loss pill, giving patients another option beyond the injectable treatments that have dominated the GLP-1 market.

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly’s orforglipron, sold under the brand name Foundayo, on August 10 for weight management and to improve blood sugar control in adults with type 2 diabetes.

Keep ReadingShow less